Invention Grant
- Patent Title: R-praziquantel preparation method
- Patent Title (中): 吡喹酮制备方法
-
Application No.: US14353485Application Date: 2012-10-26
-
Publication No.: US09175321B2Publication Date: 2015-11-03
- Inventor: Mingxin Qian
- Applicant: SUZHOU TONGLI BIOMEDICAL CO., LTD
- Applicant Address: CN Jiangsu
- Assignee: SUZHOU TONGLI BIOMEDICAL CO., LTD
- Current Assignee: SUZHOU TONGLI BIOMEDICAL CO., LTD
- Current Assignee Address: CN Jiangsu
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Michelle Glasky Bergman
- Priority: CN201110327992 20111026
- International Application: PCT/CN2012/083611 WO 20121026
- International Announcement: WO2013/060292 WO 20130502
- Main IPC: C12P17/12
- IPC: C12P17/12 ; C12P17/18 ; C07D471/04 ; C12P41/00 ; C07D217/12

Abstract:
Provided are R-praziquantel preparation methods, which utilize the characteristics of biological enzyme of strong stereoselectivity, site-selectivity, and regioselectivity, of high resolution efficiency, of mild reaction conditions, and of simple operations to catalyze the hydrolysis of a certain enantiomer in a chemically synthesized racemate or a derivative, thus acquiring a mixture of reacted and unreacted optical isomers. R-praziquantel prepared by the method can have a purity of 98% or more.
Public/Granted literature
- US20140256003A1 R-PRAZIQUANTEL PREPARATION METHOD Public/Granted day:2014-09-11
Information query